Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FLASH-003
- Development stage
- Preclinical
- Lead developer
- Flashpoint Therapeutics
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, CRISPR-Cas9 → CRISPR Systems → Programmable Nucleases → Gene Editing → Gene Therapies, Recombinant Proteins and Enzymes, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Nanoparticles → Drug Delivery Systems
01
Overview
FLASH-003 is a preclinical-stage nanomedicine candidate being developed by Flashpoint Therapeutics. It is built upon a proprietary precision-engineered structural nanomedicine platform designed to co-deliver optimized combinations of therapeutic payloads, including mRNA, DNA, proteins, and CRISPR components, directly into target cells. This multi-modal delivery approach allows for the simultaneous administration of different therapeutic agents in precise ratios to maximize efficacy and safety. FLASH-003 is being investigated for a broad range of therapeutic areas, including pain management, primary hepatocellular carcinoma (HCC), HPV-related conditions, Duchenne muscular dystrophy (DMD), and metabolic diseases such as obesity.
Beyond the preview
Go deeper on FLASH-003.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FLASH-003.